arrow
返回
M

Markus Pfirrmann

Institute for Medical Information Processing

44H指数
221论文数
8.8K被引数
收录论文 48
发表时间
FAIR by design (TRACE): A Trusted Research Access & Collaboration Environment基于设计的FAIR(TRACE):一个可信的研究访问与合作环境
err2026-09-15
err0
errOAAI
errMarcel Müller; Benjamin P. Geisler; Samar Shamas; Nikolaus v. Bomhard; Eva Hoster; Markus Pfirrmann; Ulrich Mansmann
err分享
err收藏
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study慢性髓性白血病患者治疗中断缓解和分子学复发的全面分子特征分析:EURO-SKI生物标志物研究
errLeukemia
IF13.4
err2026-06-18
err0
errOAAI
errS. Rinaldetti; M. Chepeleva; A. Hedblom; C. Sticht; M. Muciek; P. Panayiotidis; J. Richter; U. Olsson-Strömberg; D. Nowak; V. Nowak; P. Ljungman; N. von Bubnoff; K. Lotfi; L. Stenke; T. H. Brümmendorf; H. Hjorth-Hansen; T. Gedde-Dahl; W. Majeed; A. Burchert; P. V. Nazarov; E. Felde; I. Tarnopolscaia; C. Hoelting; A. Fabarius; W.-K. Hofmann; F.-X. Mahon; S. Saussele; M. Pfirrmann
err分享
err收藏
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase慢性髓性白血病急变期预后评分系统的开发
errLeukemia
IF13.4
err2026-02-19
err0
errOAAI
errMichael Lauseker; Tomasz Sacha; Hana Klamova; Julia Yakoleva; Elza Lomaia; Dragana Milojkovic; Christian Fabisch; Franck E. Nicolini; Ulla Olsson-Stromberg; Daniela Zackova; Krzysztof Lewandowski; Philipp Ernst; Fausto Castagnetti; Klaus Hirschbühl; Irena Zupan; Astghik Voskanyan; Aleksandra Gołos; Jochen J. Frietsch; Justyna Gil; Edgar Faber; Stefan W. Krause; Anne Parry; Susanne Saussele; Sonja Heibl; Georg-Nikolaus Franke; Luis Felipe Casado; Edyta Paczkowska; Holger Hebart; Matthias Eder; Peter Anhut; Karolin Trautmann-Grill; Elzbieta Szczepanek; Thomas Südhoff; Elzbieta Patkowska; Alexander Kiani; Thomas Ernst; Jane Apperley; Jiri Mayer; Andreas Hochhaus; Markus Pfirrmann; Annamaria Brioli
err分享
err收藏
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial每日一次、高剂量口服胰岛素免疫疗法在具有1型糖尿病遗传风险的儿童中的疗效(POInT):一项欧洲、随机、安慰剂对照的一级预防试验
err2025-11-11
err0
errOAAI
errAnette-Gabriele Ziegler; Peter Achenbach; Andreas Weiß; Reinhard Berner; Kristina Casteels; Helena Elding Larsson; Florian Haupt; Angela Hommel; An Jacobs; Olga Kordonouri; Markus Lundgren; Mariusz Ołtarzewski; Markus Pfirrmann; Matthew D Snape; Agnieszka Szypowska; John A Todd; Manu Vatish; Thekla von dem Berge; Christiane Winkler; Ezio Bonifacio
err分享
err收藏
Prognostic scoring systems in chronic myeloid leukaemia慢性髓性白血病中的预后评分系统
errLEUKEMIA
IF13.4
err2025-04-15
err0
errOAAI
errLauseker, Michael; Hoffmann, Verena S.; Pfirrmann, Markus
err分享
err收藏
The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML PatientsAsciminib与ATP竞争性酪氨酸激酶抑制剂的联合应用可能克服ASXL1突变对初诊CML患者分子反应的负面影响。
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errErnst, Thomas; Rinke, Jenny; le Coutre, Philipp; Crysandt, Martina; Brummendorf, Tim H. H.; Burchert, Andreas; Lang, Fabian; Saussele, Susanne; Pfirrmann, Markus; Lang, Thomas; Fabisch, Christian; Hochhaus, Andreas
err分享
err收藏
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
errLEUKEMIA
IF13.4
err2024-07-10
err2
PREAI
errEfficace, Fabio; Mahon, Francois-Xavier; Richter, Johan; Piciocchi, Alfonso; Cipriani, Marta; Nicolini, Franck E.; Mayer, Jiri; Zackova, Daniela; Janssen, Jeroen J. W. M.; Panayiotidis, Panayiotis; Vestergaard, Hanne; Koskenvesa, Perttu; Almeida, Antonio; Hjorth-Hansen, Henrik; Martinez-Lopez, Joaquin; Olsson-Stromberg, Ulla; Hochhaus, Andreas; Berger, Marc G.; Etienne, Gabriel; Klamova, Hana; Faber, Edgar; Rousselot, Philippe; Pfirrmann, Markus; Saussele, Susanne
err分享
err收藏
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
errLEUKEMIA
IF13.4
err2024-03-28
err4
errOAAI
errBrioli, Annamaria; Lomaia, Elza; Fabisch, Christian; Sacha, Tomasz; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto; Patkowska, Elzbieta; Mayer, Jiri; Hirschbuehl, Klaus; Podgornik, Helena; Paczkowska, Edyta; Parry, Anne; Ernst, Thomas; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne; Franke, Georg-Nikolaus; Kiani, Alexander; Faber, Edgar; Krause, Stefan; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Suedhoff, Thomas; Hebart, Holger; Heibl, Sonja; Pfirrmann, Markus; Hochhaus, Andreas; Lauseker, Michael
err分享
err收藏
How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to RP Gale and J. Chen
errLEUKEMIA
IF13.4
err2024-01-03
err0
errOAAI
errPfirrmann, Markus; Saussele, Susanne; Mahon, Francois-Xavier; Richter, Johan
err分享
err收藏
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib药物转运体OCTN1基因启动子中的SNP rs460089对伊马替尼治疗的慢性粒细胞白血病患者的无治疗缓解具有预后价值
errLEUKEMIA
IF13.4
err2023-12-21
err3
errOAAI
errPolakova, Katerina Machova; Albeer, Ali; Polivkova, Vaclava; Krutska, Monika; Vlcanova, Katerina; Curik, Nikola; Fabarius, Alice; Klamova, Hana; Spiess, Birgit; Waller, Cornelius F.; Bruemmendorf, Tim H.; Dengler, Jolanta; Kunzmann, Volker; Burchert, Andreas; Belohlavkova, Petra; Mustjoki, Satu; Faber, Edgar; Mayer, Jiri; Zackova, Daniela; Panayiotidis, Panayiotis; Richter, Johan; Hjorth-Hansen, Henrik; Kaminska, Magdalena; Plonka, Magdalena; Szczepanek, Elzbieta; Szarejko, Monika; Bober, Grazyna; Hus, Iwona; Grzybowska-Izydorczyk, Olga; Wasilewska, Ewa; Paczkowska, Edyta; Niesiobedzka-Krezel, Joanna; Giannopoulos, Krzysztof; Mahon, Francois X.; Sacha, Tomasz; Saussele, Susanne; Pfirrmann, Markus
err分享
err收藏
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study第二代酪氨酸激酶抑制剂 (TKI) 治疗后慢性粒细胞白血病 (CML) 慢性期患者中博舒替尼的逐步剂量: 博舒替尼剂量优化 (BODO) 研究的结果
err2023-08-18
err9
errOAAI
errIsfort, Susanne; Manz, Kirsi L.; Teichmann, Lino; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander R.; Gothert, Joachim; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Haenel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus; Wolf, Dominik H.; Bruemmendorf, Tim; German CML Study Grp
err分享
err收藏
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial
errLEUKEMIA
IF13.4
err2023-07-28
err8
errOAAI
errHammersen, J.; Birndt, S.; Doehner, K.; Reuken, P.; Stallmach, A.; Sauerbrey, P.; La Rosee, F.; Pfirrmann, M.; Fabisch, C.; Weiss, M.; Traeger, K.; Bremer, H.; Russo, S.; Illerhaus, G.; Droemann, D.; Schneider, S.; La Rosee, P.; Hochhaus, A.
err分享
err收藏
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study60岁以上新诊断AML患者的不同治疗策略与共同标准臂 (CSA): 一项随机德国组间研究
err2023-01-25
err5
errOAAI
errNiederwieser, Dietger; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Kraemer, Alwin; Junghanss, Christian; Muegge, Lars-Olof; Haehling, Detlev; Hirt, Carsten; Spaeth, Christian; Peter, Norma; Opitz, Bernhard; Florschuetz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Poenisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schuette, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Doerken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Woermann, Bernhard; Mueller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Ruediger; Berdel, Wolfgang E.; Pfirrmann, Markus; Krug, Utz; Hoffmann, Verena S.
err分享
err收藏
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
errLEUKEMIA
IF13.4
err2022-07-28
err26
errOAAI
errSchoenfeld, Lioba; Rinke, Jenny; Hinze, Anna; Nagel, Saskia N.; Schaefer, Vivien; Schenk, Thomas; Fabisch, Christian; Bruemmendorf, Tim H.; Burchert, Andreas; le Coutre, Philipp; Krause, Stefan W.; Saussele, Susanne; Safizadeh, Fatemeh; Pfirrmann, Markus; Hochhaus, Andreas; Ernst, Thomas
err分享
err收藏
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial1型糖尿病高危儿童口服胰岛素免疫治疗的随机对照试验
err2021-01-30
err36
errOAAI
errAssfalg, Robin; Knoop, Jan; Hoffman, Kristi L.; Pfirrmann, Markus; Zapardiel-Gonzalo, Jose Maria; Hofelich, Anna; Eugster, Anne; Weigelt, Marc; Matzke, Claudia; Reinhardt, Julia; Fuchs, Yannick; Bunk, Melanie; Weiss, Andreas; Hippich, Markus; Halfter, Kathrin; Hauck, Stefanie M.; Hasford, Jorg; Petrosino, Joseph F.; Achenbach, Peter; Bonifacio, Ezio; Ziegler, Anette-Gabriele
err分享
err收藏
High-risk additional chromosomal abnormalities at low blast counts herald death by CML (vol 34, pg 2074, 2020)
errLEUKEMIA
IF13.4
err2020-09-10
err2
errOAAI
errHehlmann, Rudiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Kalmanti, Lida; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Haferlach, Claudia; Schlegelberger, Brigitte; Fabarius, Alice; Seifarth, Wolfgang; Spiess, Birgit; Wuchter, Patrick; Krause, Stefan; Kolb, Hans-Jochem; Neubauer, Andreas; Hossfeld, Dieter K.; Nerl, Christoph; Gratwohl, Alois; Baerlocher, Gabriela M.; Burchert, Andreas; Bruemmendorf, Tim H.; Hasford, Joerg; Hochhaus, Andreas; Saussele, Susanne; Baccarani, Michele
err分享
err收藏
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
errLEUKEMIA
IF13.4
err2020-06-29
err45
errOAAI
errPfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, Francois; Heibl, Sonja; Hehlmann, Rudiger; Faber, Edgar; Turkina, Anna; Ossenkoppele, Gert; Hoglund, Martin; Zaritskey, Andrey; Griskevicius, Laimonas; Olsson-Stromberg, Ulla; Everaus, Hele; Koskenvesa, Perttu; Labar, Boris; Sacha, Tomasz; Zackova, Daniela; Cervantes, Francisco; Colita, Adriana; Zupan, Irena; Bogdanovic, Andrija; Castagnetti, Fausto; Guilhot, Joelle; Hasford, Joerg; Hochhaus, Andreas; Hoffmann, Verena S.
err分享
err收藏
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
errLEUKEMIA
IF13.4
err2020-05-07
err53
errOAAI
errHehlmann, Ruediger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Kalmanti, Lida; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Haferlach, Claudia; Schlegelberger, Brigitte; Fabarius, Alice; Seifarth, Wolfgang; Spiess, Birgit; Wuchter, Patrick; Krause, Stefan; Kolb, Hans-Jochem; Neubauer, Andreas; Hossfeld, Dieter K.; Nerl, Christoph; Gratwohl, Alois; Baerlocher, Gabriela M.; Burchert, Andreas; Bruemmendorf, Tim H.; Hasford, Joerg; Hochhaus, Andreas; Saussele, Susanne; Baccarani, Michele
err分享
err收藏
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
err2019-09-14
err20
errOAAI
errLauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Stromberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas; Pfirrmann, Markus
err分享
err收藏
err分享
err收藏